Bokf, Na Novartis Ag Transaction History

Bokf, Na

$5.65 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$92.57 - $107.37 $108,677 - $126,052	-1,174 Reduced 6.1%	18,078 $1.92 Million
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $102,510 - $116,713	-1,076 Reduced 5.29%	19,252 $1.86 Million
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $284,376 - $312,946	-3,082 Reduced 13.17%	20,328 $2.05 Million
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $165,019 - $183,136	-1,742 Reduced 6.93%	23,410 $2.38 Million
Q2 2023 Aug 21, 2023	SELL	$92.52 - $104.91 $198,455 - $225,031	-2,145 Reduced 7.86%	25,152 $2.54 Million
Q1 2023 May 11, 2023	SELL	$80.03 - $92.81 $397,669 - $461,172	-4,969 Reduced 15.4%	27,297 $2.51 Million
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $67,239 - $82,342	890 Added 2.84%	32,266 $2.93 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $22,159 - $25,916	-297 Reduced 0.94%	31,376 $2.39 Million
Q2 2022 Aug 11, 2022	SELL	$80.52 - $93.75 $311,692 - $362,906	-3,871 Reduced 10.89%	31,673 $2.68 Million
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $446,773 - $505,387	-5,577 Reduced 13.56%	35,544 $3.12 Million
Q4 2021 Mar 11, 2022	BUY	$79.7 - $88.13 $638,317 - $705,833	8,009 Added 24.19%	41,121 $3.6 Million
Q3 2021 Nov 10, 2021	BUY	$81.78 - $95.14 $452,815 - $526,790	5,537 Added 20.08%	33,112 $2.71 Million
Q1 2021 Apr 21, 2021	SELL	$83.5 - $98.47 $428,438 - $505,249	-5,131 Reduced 15.69%	27,575 $2.36 Million
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $362,791 - $438,816	-4,647 Reduced 12.44%	32,706 $3.09 Million
Q3 2020 Oct 30, 2020	SELL	$82.14 - $91.0 $725,542 - $803,803	-8,833 Reduced 19.12%	37,353 $3.25 Million
Q2 2020 Aug 12, 2020	BUY	$80.93 - $91.1 $617,172 - $694,728	7,626 Added 19.78%	46,186 $4.03 Million
Q1 2020 May 13, 2020	SELL	$70.67 - $99.01 $108,266 - $151,683	-1,532 Reduced 3.82%	38,560 $3.18 Million
Q4 2019 Feb 12, 2020	BUY	$84.35 - $95.37 $989,256 - $1.12 Million	11,728 Added 41.35%	40,092 $3.8 Million
Q3 2019 Nov 13, 2019	BUY	$85.54 - $94.26 $85,368 - $94,071	998 Added 3.65%	28,364 $2.47 Million
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $405,576 - $499,171	-5,379 Reduced 16.43%	27,366 $2.5 Million
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $55,887 - $63,923	742 Added 2.32%	32,745 $3.15 Million
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $148,130 - $164,942	-2,011 Reduced 5.91%	32,003 $2.75 Million
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $83,942 - $97,097	1,254 Added 3.83%	34,014 $2.93 Million
Q2 2018 Aug 13, 2018	BUY	$64.91 - $73.36 $464,690 - $525,184	7,159 Added 27.96%	32,760 $2.48 Million
Q1 2018 May 14, 2018	BUY	$70.39 - $84.15 $112,905 - $134,976	1,604 Added 6.68%	25,601 $2.07 Million
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $65,386 - $70,186	-904 Reduced 3.63%	23,997 $2.02 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $12,752 - $13,290	172 Added 0.7%	24,901 $2.14 Million
Q2 2017 Aug 14, 2017	BUY	N/A	24,729	24,729 $2.07 Million

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Account